The era of antiaging ophthalmology comes of age: Antiaging approach for dry eye treatment

Ophthalmic Research

Volumn 44, Issue 3, 2010, Pages 146-154

  Tsubota, Kazuo ^a   Kawashima, Motoko ^a   Inaba, Takaaki ^a   Dogru, Murat ^a   Ogawa, Yoko ^a   Nakamura, Shigeru ^a   Shinmura, Ken ^a   Higuchi, Akihiro ^a   Kawakita, Tetsuya ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Calorie restriction; Dry eye; Reactive oxygen species

Indexed keywords

BUTEIN; CATALASE; CYCLOSPORIN A; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN; SUPEROXIDE DISMUTASE;

AGING; CALORIC INTAKE; CALORIC RESTRICTION; CATARACT; CLINICAL RESEARCH; DOWN REGULATION; DRY EYE; ENZYME ACTIVITY; EYE DISEASE; HUMAN; LACRIMAL GLAND DISEASE; LIPID DIET; NONHUMAN; PERSONAL EXPERIENCE; PHOTOAGING; PRIORITY JOURNAL; RADIATION EXPOSURE; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS; REVIEW; RISK FACTOR; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

AGING; ANIMALS; CALORIC RESTRICTION; DRY EYE SYNDROMES; FREE RADICAL SCAVENGERS; HUMANS; REACTIVE OXYGEN SPECIES;

EID: 77956570254     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316594     Document Type: Review

References (56)

1. Uchino M, Schaumberg DA, Dogru M, Uchi-no Y, Fukagawa K, Shimmura S, Satoh T, Takebayashi T, Tsubota K: Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008; 115: 1982-1988.
2. Uchino M, Dog r u M, Uchi no Y, Fukagawa K, Shimmura S, Takebayashi T, Schaumberg DA, Tsubota K: Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Oph-thalmol 2008; 146:925-929.
3. Uchino M, Dogru M, Yagi Y, Goto E, Tomita M, Kon T, Saiki M, Matsumoto Y, Uchino Y, Yokoi N, Kinoshita S, Tsubota K: The features of dry eye disease in a Japanese elderly population. Optom Vis Sci 2006; 83: 797-802.
4. Xu K, Yagi Y, Tsubota K: Decrease in corneal sensitivity and changes in tear function in dr y eye. Cornea 1996; 15: 235-239.
5. Bordone L, Guarente L: Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005; 6:298-305.
6. Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO: Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 2008; 7:681-687.
7. Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
8. Guarente L: Sirtuins as potential targets for metabolic syndrome. Nature 2006; 444: 868-874.
9. Imai S, Armstrong CM, Kaeberlein M, Gua-rente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403:795-800.
10. Lee SJ, Murphy CT, Kenyon C: Glucose shortens the life span of C. elegans by down-regulating DAF-16/FOXO activity and aqua-porin gene expression. Cell Metab 2009; 10: 379-391.
11. Spindler SR: Calorie restriction enhances the expression of key metabolic enzymes associated with protein renewal during aging. Ann NY Acad Sci 2001; 928:296-304.
12. Blagosklonny MV: An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007; 12: 218-224.
13. Heilbronn LK, de Jonge L, Frisard MI, De Lany JP, Larson-Meyer DE, Rood J, et al.: Effect of 6-month calorie restriction on bio-markers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 2006; 295: 1539-1548.
14. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 20 03; 425: 191-196.
15. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu V V, et al.: Resvera-trol improves health and survival of mice on a high-ca lorie diet. Nature 2006; 444: 337-342.
16. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al.: Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008; 8:157-168.
17. Guarente L: Mitochondria-a nexus for aging, calorie restriction, and sirtuins? Cell 2008; 132: 17 1-176.
18. Longo VD, Kennedy BK: Sirtuins in aging and age-related disease. Cell 2006; 126:257-268.
19. Matsuzawa Y: Therapy insight: adipocyto-kines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Car-diovasc Med 2006; 3: 35-42.
20. Abe T, Nakajima A, Satoh N, Ohkoshi M, Sakuragi S, Koizumi A: Suppression of experimental autoimmune uveoretinitis by dietary calorie restriction. Jpn J Ophthalmol 2001; 45:46-52.
21. Obin M, Halbleib M, Lipman R, Carroll K, Taylor A, Bronson R: Calorie restriction increases light-dependent photoreceptor cell loss in the neural retina of Fischer 344 rats. Neurobiol Aging 2000; 21:639-645.
22. Li Y, Wolf NS: Effects of age and long-term caloric restriction on the aqueous collecting channel in the mouse eye. J Glaucoma 1997; 6:18-22.
23. Ishii N, Fujii M, Hartman PS, Tsuda M, Ya-suda K, Senoo-Matsuda N, Yanase S, Ayu-sawa D, Suzuki K: A mutation in succinate dehydrogenase cytochrome b causes oxida-tive stress and ageing in nematodes. Nature 1998; 394: 694-697.
24. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS: Extension of murine life span by overexpression of cata-lase targeted to mitochondria. Science 2005; 308: 1909-1911.
25. Sun J, Folk D, Bradley TJ, Tower J: Induced overexpression of mitochondrial Mn-super-oxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 2002; 161: 661-672.
26. Kawashima M, Kawakita T, Okada N, Ogawa Y, Murat D, Nakamura S, Nakashima H, Shimmura S, Shinmura K, Tsubota K: Calorie restriction: a new therapeutic intervention for age-related dry eye disease in rats: Biochem Biophys Res Commun 2010;397: 724-728.
27. Kubota S, Kurihara T, Mochimaru H, Sato-fuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K: Prevention of ocular inflammation in endotoxin-induced uveitis with res-veratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophtha lmol Vis Sci 2009; 50: 3512-3519.
28. Bressler NM, Bressler SB, Congdon NG, Ferris FL 3rd, Friedman DS, Klein R, Lindblad AS, Milton RC, Seddon JM; Age-Related Eye Disease Study Research Group: Potential pu bl ic hea lt h i mp ac t of A ge-R e l at e d Eye Di s-ease Study results: AREDS report No 11. Arch Ophthalmol 2003; 121:1621-1624.
29. Sackett CS, Schenning S: The Age-Related Eye Disease Study: the results of the clinical trial. Insight 2002; 27:5-7.
30. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group: Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report No 19. Oph-thalmolog y 2005; 11 2: 533-539.
31. Erie JC, Good JA, Butz JA: Excess lead in the neural retina in age-related macular degeneration. Am J Ophthalmol 2009; 148:890-894.
32. Wills NK, Kalariya N, Sadagopa Ramanu-jam VM, Lewis JR, Haji Abdollahi S, Husain A, van Kuijk FJ: Human retinal cadmium accumulation as a factor in the etiology of age-related macular degeneration. Exp Eye Res 2009; 89: 79-87.
33. Yuki K, Dogru M, Imamura Y, Kimura I, Ohtake Y, Tsubota K: Lead accumulation as possible risk factor for primary open-angle glaucoma. Biol Trace Elem Res 2009, E-pub ahead of print.
34. Coleman H, Chew E: Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 2007; 18: 220-223.
35. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K: Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 2009; 50:1433-1439.
36. Izumi-Nagai K, Nagai N, Ohgami K, Sato-fuk a S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S: Inhibition of choroidal neovascu-larization with an anti-inflammatory carot-enoid astaxanthin. Invest Ophthalmol Vis Sci 2008; 49:1679-1685.
37. Nakamura S, Shibuya M, Nakashima H, Hisamura R, Masuda N, Imagawa T, Uehara M, Tsubota K: Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthal-mol Vis Sci 2007; 48: 1552-1558.
38. Nakamura S, Kinoshita S, Yokoi N, Ogawa Y, Shibuya M, Nakashima H, Hisamura R, Ima-da T, Imagawa T, Uehara M, Shibuya I, Dogru M, Ward S, Tsubota K: Lacrimal hy-pofunction as a new mechanism of dry eye in visual display terminal users. 2010 PLoS ON E 5:e11119.
39. Rummenie VT, Matsumoto Y, Dogru M, Wang Y, Hu Y, Ward SK, Igarashi A, Waka-matsu T, I bra him O, G oto E, Luy ten G, Inoue H, Saito I, Shimazaki J, Tsubota K: Tear cy-tokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine 2008; 43:200-208.
40. Matsumoto Y, Dogru M, Goto E, Sasaki Y, Inoue H, Saito I, Shimazaki J, Tsubota K: Alterations of the tear film and ocular surface health in chronic smokers. Eye (Lond) 2008; 22: 961-968.
41. Altinors DD, Akça S, Akova YA, Bilezikçi B, Goto E, Dogru M, Tsubota K: Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol 2006; 141: 1016-1021.
42. Schaumberg DA, Sullivan DA, Buring JE, Dana MR: Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318-3 2 6.
43. Dogru M, Matsumoto Y, Yamamoto Y, Goto E, Saiki M, Shimazaki J, Takebayashi T, Tsubota K: Lactoferrin in Sjögren's syndrome. Ophthalmology 2007; 114: 2366-2367.
44. Wakamatsu TH, Dogru M, Tsubota K: Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol 2008; 71(suppl):72-79.
45. Higuchi A, Shimmura S, Takeuchi T, Sue-matsu M, Tsubota K: Elucidation of apopto-sis induced by serum deprivation in cultured conjunctival epithelial cells. Br J Ophthal-mol 2006; 90:760-764.
46. Higuchi A, Ueno R, Shimmura S, Suematsu M, Dogru M, Tsubota K: Albumin rescues ocular epithelial cells from cell death in dry eye. Curr Eye Res 20 07; 32: 83-88.
47. Higuchi A, Takahashi K, Hirashima M, Kawakita T, Tsubota K: Selenoprotein p controls oxidative stress in cornea. 2010 PLoS ONE 5:e9911.
48. Todes C: Inside parkinsonism. a psychiatrist's personal experience. Lancet 1983;i: 977-978.
49. Dry Eye Society. http://www.dryeye.ne.jp.
50. Goto E, Shimazaki J, Monden Y, Takano Y, Yagi Y, Shimmura S, Tsubota K: Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 2002; 109:2030-2035.
51. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S: Treatment of dry eye by autologous serum application in Sjögren's sy ndrome. Br J Ophthalmol 1999; 83: 39 0-395.
52. Tsubota K, Yamada M, Urayama K: Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea 1994; 13: 197-201.
53. Hori-Komai Y, Toda I, Tsubota K: Laser in situ keratomileusis: assocciation with increased width of palpebral fissure. Am J Ophthalmol 2001; 131: 254-255.
54. Japanese Society of Anti-Aging Medicine. http://www.anti-aging.gr.jp.
55. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325: 201-204.
56. Curtis R, Geesaman BJ, Di Stefano PS: Ageing and metabolism: drug discovery oppor-tunit ies. Nat Rev Drug Discov 2005; 4: 569-580.